Fundamental Analysis
85 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +2113.8% | +1251.0% | 3 / 3 | +18.7% | +6.58 pp | +8.50 pp | +12.6% | 0.20 | 5.28 | 78,3 | +18,7% | 7,0 | +2.335,1% | 5.28 | 9.95 | −46,9% |
| Pts | 12 | 12 | 12 | 8 | 12 | 12 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 13.500 (close price on 2026-10-13)EPS (TTM): 2.557
Financial charts
1.Revenue & growth
VND bn78,3Q2/26
1.Revenue & growth
VND bn78,3Q2/26
2.Profit & growth
VND bn6,99Q2/26
3.Profit mix (Penman)
VND bn30,9Q2/26
4.Margins & cost structure
%23.5%Q2/26
5.Returns & cash cycle
% · days13.2%Q2/26
6.Earnings quality & cash
VND bn33,2Q2/26
7.Asset structure
VND bn293Q2/26
8.Funding & debt health
VND bn · times293Q2/26
9.Revenue backlog
VND bn9,10Q2/26
10.Valuation
times · %5,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %728Q2/26
Adjusted EPS growth, latest quarter
24,4× higher
Average adjusted EPS growth, 3 quarters
14,2× higher
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
-0.0%
Source: vnstockData through Q2/26